Jun 19, 2021 08:49 PM IST
The new order, allowing inbound passengers from South Africa, Nigeria and India to Dubai, will be effective from June 23 onwards.
- Jun 01, 2021 08:58 PM IST
The U.N. health agency said data submitted to its experts showed that two doses of the vaccine prevented people from getting symptoms of COVID-19 in about half of those who got the vaccine.
- Apr 30, 2021 09:14 AM IST
No detailed efficacy data of Sinopharm's vaccine has been publicly released, but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said the vaccine was 79.34% effective in preventing people from developing the disease, based on interim data.
- Mar 20, 2021 11:35 AM IST
The Bahraini climbers’ team promised 2,000 vaccine doses for villagers and Nepal assumed the doses would be of AstraZeneca’s while the visitors landed with Sinopharm’s offering in tow.
- Mar 13, 2021 05:02 PM IST
China had administered 52.5 million vaccine doses through the end of February.
- Jan 20, 2021 08:44 PM IST
In the initial phase, India will inoculate about one crore healthcare workers. This will be followed by two crore frontline workers, police, armed forces, municipal workers, revenue staff and others. In the third phase, 27 crore people above 50 years of age and those with co-morbidities.
- Dec 31, 2020 09:18 AM IST
No detailed efficacy data of the vaccine has been publicly released but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said on Wednesday its vaccine was 79.34% effective in preventing people from developing the disease based on interim data.
- Nov 26, 2020 03:41 PM IST
Despite none of the Chinese firms has released any public data on the efficacy of their shots in Phase III trials, people in the Asian countries are bending the rules to get hold of the unproven Chinese vaccines.
- Nov 03, 2020 07:40 PM IST
Sheikh Mohammed took to Twitter to make the announcement by sharing a photograph of himself getting the coronavirus vaccine shot. The shot is now in the third and final stage of clinical trials.
- Sep 16, 2020 12:25 PM IST
Aiming to protect essential workers and reduce the likelihood of a resurgence, the vaccines are also grabbing attention in the global scramble by governments to secure supplies, potentially helping reframe China's perceived role in the pandemic.
- Sep 07, 2020 04:56 PM IST
High hopes hang on the vaccine candidates produced by Chinese companies Sinovac Biotech and Sinopharm on display at a Beijing trade fair this week
- Aug 18, 2020 04:10 PM IST
Liu Jingzhen, the chairman of SinoPharm, told a Chinese Communist Party newspaper that the vaccine would cost less than 1,000 yuan ($140) and be given in two shots, 28 days apart.
- Jul 23, 2020 02:50 PM IST
Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV that the company expects to finish late-stage human testing within about three months.
- Jul 16, 2020 05:48 PM IST
The human trial is a partnership between Sinopharm's China National Biotec Group (CNBG), Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) and the Abu Dhabi Department of Health.
- Jan 11, 2011 03:24 PM IST
Indian drugmaker Aurobindo Pharma said on Tuesday it has signed a definitive agreement to divest 51% stake in its Chinese joint venture.